Clinical Trial Update: Gemcitabine and Bevacizumab in Treating Patients With Pancreatic Cancer That Has Been Completely Removed By Surgery [Phase 1, Phase 2]

View source ↗

Summary

A Phase 1/2 clinical trial evaluating gemcitabine with bevacizumab for pancreatic cancer that has been completely removed by surgery was terminated.

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Pancreatic Cancer

Drugs mentioned

• Avastin (bevacizumab)
• Gemzar (gemcitabine)

Snippet

Sponsor: University of California, San Francisco | Conditions: Pancreatic Cancer | Phase 1, Phase 2 | Status: TERMINATED